Depth, breadth and quality to support your research needs
Capturing a complete picture of the patient health care journey does not happen with claims data alone. Clinical research, medication adherence analysis, value messaging and commercialization strategies all depend on data that sufficiently reflect what occurs during diagnosis and treatment.
Unlike niche data aggregators, Optum consolidates and enriches electronic health record (EHR) data that span therapeutic areas and sites of care. Our scale — with over 100 million unique lives — lets researchers drill down into the treatment patterns and resulting care outcomes that matter for the population they're studying.
Optum remains at the forefront of using natural language processing (NLP) to provide meaning, structure and context to clinical notes. That means more opportunities for enrichment and more precise insight to help you understand where your treatment has the greatest opportunity to impact patient outcomes.
Some of the commercially available data sets source data solely from oncology clinics, which may not reflect patients’ full care journey.
Carnegie, Argentinis, et al.
Journal of Clinical Oncology, May 2020
Product sheet
Gain a fuller view of the patient experience with EHR data
How can Optum Electronic Health Record (EHR) data help your company answer critical questions? Get an in-depth look at our EHR asset.
Explore these related perspectives
6 guiding steps for selecting a fit-for-purpose data set
Is Your Real-World Data Research Ready?
Real-world data centralized teams
Discover our real-world data resources
Clinicogenomics data
Better understand diseases and drug development opportunities.
Market Clarity: Linked EHR and claims data
Unlock insights using the industry’s largest and most trusted repository of longitudinal clinical and claims data.
Claims data
Track utilization and costs through medical and pharmacy claims, lab test results, and member and provider demographics.
1. Journal of Clinical Oncology. The role of non-oncology specialties in the real world longitudinal journey of prostate cancer patients. Reviewed May, 2020. Accessed June 3, 2022